Business Problem: 
Restricted access to TAA/AAA Endovascular Stent Grafts despite high quality clinical data for high risk patient groups. Funding for devices restricted and contracting.

Solution: 
Encourage development of Canadian Society of Vascular Surgery position paper on issue, supported by high quality outcome data. Engage technology assessment groups in issue. Public relations to highlight problems related to lack of access for hghi risk patients.

Outcome: 
Breakthrough funding for Endovascular Stent Grafts. “This technology if used properly saves lives and reduces complications”, Dr. Thomas Lindsay told CTV News. “This is accepted practice around the world and should be accepted as the standard of care in Canada.” New funding envelope for TAA/AAA Endovascular Stent Grafts created. Improved patient access for high risk patients.